BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625), today announced that the Company will present new data from ongoing research and development of its artificial liver device technology in three presentations at the 54th Annual Meeting of the American Society of Artificial Internal Organs (ASAIO), June 19-21, 2008. The conference, “Concept to Commercialization of Organ Replacement & Repair Therapies,” will be held at the Hilton Hotel in San Francisco, California.
